Movement disorders: towards new therapies in Parkinson's disease

被引：0
作者：
Antonini, Angelo [1 ]
机构：
[1] IRCCS San Camillo, Dept Parkinsons Dis, Venice, Italy
来源：
LANCET NEUROLOGY | 2012年 / 11卷 / 01期
关键词：
SHAM-SURGERY; DOUBLE-BLIND; TRIAL; CELLS;
D O I：
10.1016/S1474-4422(11)70284-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [21] Harnessing the Power of Placebos in Movement Disorders: Insights From Parkinson's Disease in Clinical Research and Practice
    Mestre, Tiago A.
    Shamy, Michel
    Benedetti, Fabrizio
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2018, 33 (08) : 1195 - 1203
  • [22] Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement Disorders
    Quik, Maryka
    Bordia, Tanuja
    Zhang, Danhui
    Perez, Xiomara A.
    NICOTINE USE IN MENTAL ILLNESS AND NEUROLOGICAL DISORDERS, 2015, 124 : 247 - 271
  • [23] Dysautonomia Rating Scales in Parkinson's Disease: Sialorrhea, Dysphagia, and Constipation-Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease
    Evatt, Marian L.
    Chaudhuri, K. Ray
    Chou, Kelvin L.
    Cubo, Ester
    Hinson, Vanessa
    Kompoliti, Katie
    Yang, Chengwu
    Poewe, Werner
    Rascol, Olivier
    Sampaio, Cristina
    Stebbins, Glenn T.
    Goetz, Christopher G.
    MOVEMENT DISORDERS, 2009, 24 (05) : 635 - 646
  • [24] Emerging therapies in Parkinson disease - repurposed drugs and new approaches
    Elkouzi, Ahmad
    Vedam-Mai, Vinata
    Eisinger, Robert S.
    Okun, Michael S.
    NATURE REVIEWS NEUROLOGY, 2019, 15 (04) : 204 - 223
  • [25] Serotonin and Parkinson's Disease: On Movement, Mood, and Madness
    Fox, Susan H.
    Chuang, Rosalind
    Brotchie, Jonathan M.
    MOVEMENT DISORDERS, 2009, 24 (09) : 1255 - 1266
  • [26] Parkinson's Disease 2 The pathogenesis of Parkinson's disease
    Morris, Huw R.
    Spillantini, Maria Grazia
    Sue, Carolyn M.
    Williams-Gray, Caroline H.
    LANCET, 2024, 403 (10423) : 293 - 304
  • [27] New small molecules for the treatment of Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (09) : 1077 - 1086
  • [28] Rationale and patient selection for interventional therapies in Parkinson's disease
    Siddiqui, Junaid
    Aldaajani, Zakiyah
    Mehanna, Raja
    Changizi, Barbara Kelly
    Bhatti, Danish
    Al-Johani, Ziyad Ghazi
    Shukla, Aparna Wagle
    Fernandez, Hubert H.
    Bajwa, Jawad A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (11) : 811 - 823
  • [29] Advanced therapies in Parkinson's disease: an individualized approach to their indication
    Schroeter, Nils
    Sajonz, Bastian E. A.
    Jost, Wolfgang H.
    Rijntjes, Michel
    Coenen, Volker A.
    Groppa, Sergiu
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (11) : 1285 - 1293
  • [30] What's New in Movement Disorders 2011
    Oberschmidt, C.
    Hilker, R.
    Kang, J. S.
    AKTUELLE NEUROLOGIE, 2011, 38 (05) : 222 - 233
12345